ReviewDrugs2008
Disease-modifying agents for multiple sclerosis: recent advances and future prospects.
Til Menge et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this paperpooled ittrialcites it
ReviewDrugs2008
Til Menge et al.PubMed ↗Publisher ↗
No numbers read from the abstract.